Erratum

In the article "Pediatric Endocrine Society Annual Meeting (PES 2025), National Harbor, MD, USA, May 15-18, 2025: Abstracts" Horm Res Paediatr. 2025;98(suppl 3):4-348; https://doi.org/10.1159/000549079, two abstracts were not correctly published in error by the conference organizers. The organizers apologize for the inconvenience and provide the two aforementioned abstracts below.PosterAbstract 1420THE UTILITY OF GROWTH VELOCITY DATA IN DETERMINING THE SEVERITY OF IDIOPATHIC GROWTH HORMONE DEFICIENCYRohan Henry, MD, MS, Nationwide Children's Hospital; Leena Mamilly, MD, Nationwide Children's Hospital; Monika Chaudhari, MD; Amy Pyle-Eiolola, PhD, Nationwide Children's HospitalBackground/Objectives: It is believed by some that growth hormone (GH) secretion exists on a continuum. As such, classification of idiopathic growth hormone deficiency seen as the most common etiology of growth hormone deficiency (GHD), include classical or partial based on severity as defined by peak stimulated growth hormone levels (pGH). Though response to GH therapy is purported to be commensurate with GHD severity, this hypothesis has not been tested. The study aims to determine if there is a difference in GH therapeutic response of GHD cases as defined by growth velocity (GV) based on peak stimulated growth hormone (pGH) levels and MRI findings. METHODS: Retrospective chart review of GHD cases diagnosed between 3 and 16 years according to GHD severity (pGH 0.70 indicating good internal consistency. Pearson's correlation coefficient (r) showed moderate (r > 0.3) to strong (r > 0.5) positive correlations among most of the QoLISSY subscales and the total score in both parent and participant reports (Table 1). Strong positive correlations were found between the parent report and the participant reports (r = 0.83).The short stature-specific QoLISSY questionnaire could be a valuable tool in assessing QoL with respect to short stature in girls with TS with good internal consistency and strong positive correlations.